We are live on ! Find out more
CF

CNA Financial Portfolio holdings

AUM $235M
1-Year Est. Return 3.39%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+3.39%
3 Year Est. Return
+50.54%
5 Year Est. Return
+66.93%
10 Year Est. Return
+254.04%
AUM
$353M
AUM Growth
+$27.6M
Cap. Flow
+$11.6M
Cap. Flow %
3.28%
Top 10 Hldgs %
25.17%
Holding
214
New
16
Increased
71
Reduced
52
Closed
19

Top Buys

Rank Stock Value
1
GRSV
Gores Holdings V, Inc.
GRSV
+$11.2M
2
GM icon
General Motors
GM
+$5.88M
3
CSGP icon
CoStar Group
CSGP
+$4.32M
4
EPD icon
Enterprise Products Partners
EPD
+$2.37M
5
DNB
Dun & Bradstreet
DNB
+$2.24M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$5.29M
2
CSCO icon
Cisco
CSCO
+$4.14M
3
AHCO icon
AdaptHealth
AHCO
+$3.68M
4
CME icon
CME Group
CME
+$1.79M
5
CVS icon
CVS Health
CVS
+$1.64M

Sector Composition

Rank Sector Weight
1 Technology 23.29%
2 Healthcare 18.9%
3 Financials 14.11%
4 Industrials 11.16%
5 Consumer Discretionary 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EAR
151
DELISTED
Eargo, Inc. Common Stock
EAR
$581K 0.16%
728
– –
TMCI icon
152
Treace Medical Concepts
TMCI
$260M
$578K 0.16%
+18,504
New +$589K
VIR icon
153
Vir Biotechnology
VIR
$1.49B
$565K 0.16%
11,942
+1,070
+10% +$48.6K
HLLY icon
154
Holley
HLLY
$336M
$561K 0.16%
56,092
+33,367
+147% +$334K
LBRDK icon
155
Liberty Broadband Class C
LBRDK
$4.72B
$559K 0.16%
3,217
– –
INSM icon
156
Insmed
INSM
$22.6B
$551K 0.16%
19,344
+1,350
+8% +$40.1K
ARRY icon
157
Array Technologies
ARRY
$785M
$546K 0.15%
35,022
-1,110
-3% -$23.4K
EYE icon
158
National Vision
EYE
$1.75B
$545K 0.15%
+10,650
New +$522K
RVNC
159
DELISTED
Revance Therapeutics, Inc.
RVNC
$507K 0.14%
17,100
-2,700
-14% -$77.9K
ACVA icon
160
ACV Auctions
ACVA
$1.43B
$505K 0.14%
+19,687
New +$574K
CHEF icon
161
Chefs' Warehouse
CHEF
$4.09B
$493K 0.14%
+15,480
New +$495K
FSR
162
DELISTED
Fisker Inc.
FSR
$493K 0.14%
25,580
+8,130
+47% +$120K
JBI icon
163
Janus International
JBI
$732M
$492K 0.14%
+34,836
New +$481K
RXRX icon
164
Recursion Pharmaceuticals
RXRX
$1.62B
$490K 0.14%
+13,432
New +$398K
FA icon
165
First Advantage
FA
$3.58B
$488K 0.14%
+24,500
New +$497K
ZNTL icon
166
Zentalis Pharmaceuticals
ZNTL
$329M
$482K 0.14%
9,066
-2,380
-21% -$127K
ALLK
167
DELISTED
Allakos
ALLK
$464K 0.13%
5,440
+350
+7% +$35K
MSGS icon
168
Madison Square Garden
MSGS
$9.58B
$454K 0.13%
2,631
– –
SLQT icon
169
SelectQuote
SLQT
$132M
$454K 0.13%
23,560
-11,692
-33% -$292K
ALLO icon
170
Allogene Therapeutics
ALLO
$573M
$450K 0.13%
17,271
+2,295
+15% +$65.4K
YMAB
171
DELISTED
Y-mAbs Therapeutics
YMAB
$449K 0.13%
13,290
+910
+7% +$29.2K
LEGN icon
172
Legend Biotech
LEGN
$3.68B
$438K 0.12%
10,665
-1,867
-15% -$63.5K
RLAY icon
173
Relay Therapeutics
RLAY
$3.99B
$436K 0.12%
11,909
+1,060
+10% +$34.9K
ALTR
174
DELISTED
Altair Engineering Inc
ALTR
$435K 0.12%
6,311
– –
TIL icon
175
Instil Bio
TIL
$49.4M
$422K 0.12%
1,092
+161
+17% +$59.7K
5 6
7
8 9

Similar funds

JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
IGYL
I.G.Y. Ltd London, United Kingdom $235M AUM 5.63% 1-Year Est. Return
CWL
Causey Wealth LLC Greenwood Village, Colorado $236M AUM 14.5% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
BWM
Bernard Wealth Management Royal Oak, Michigan $234M AUM 27.82% 1-Year Est. Return
GCM
Gables Capital Management Miami, Florida $236M AUM 32.91% 1-Year Est. Return
RP
Raelipskie Partnership Waterloo, Ontario, Canada $236M AUM 19.33% 1-Year Est. Return
KTM
Keeler Thomas Management Orem, Utah $236M AUM 10.79% 1-Year Est. Return

CNA Financial's Q2 2021 Portfolio in Review

As of Q2 2021, CNA Financial held 214 positions worth $353M, up 8.5% from $326M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

CNA Financial deployed $11.6M of net new capital in Q2 2021, opening 16 new positions and adding to 71 existing holdings. Its largest new stake was Gores Holdings V, Inc.: 1,096,000 shares worth $11.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CME Group, an estimated $1.79M trimmed.

  • CNA Financial's largest Q2 2021 buy was Gores Holdings V, Inc.: 1,096,000 shares worth $11.1M.
  • CNA Financial added most to Enterprise Products Partners in Q2 2021, an estimated $2.37M increase.
  • CNA Financial's biggest Q2 2021 reduction was CME Group, cutting an estimated $1.79M.
  • CNA Financial fully exited Visa in Q2 2021, selling an estimated $5.29M.
  • CNA Financial's ten largest holdings make up 25% of its $353M portfolio in Q2 2021.
  • CNA Financial opened 16 new positions and closed 19 in Q2 2021.
  • CNA Financial's portfolio value rose 8.5% quarter-over-quarter to $353M.

Based on CNA Financial's 13F filing for Q2 2021, filed 12 Aug 2021.